Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
27 Cards in this Set
- Front
- Back
|
Intramuscular Injection equipment: adult
|
Syringe size: 3-5 cc
Needle size: 19-23 gauge 1 - 1 1/2" |
|
|
Intramuscular Injection equipment: Infant and Young adult
|
Syringe size: 1/2 - 1 cc
Needle size: 25-27 gauge 1/2 - 1" |
|
|
Intramuscular Dosage
|
up to 3 cc max
|
|
|
Angle of Insertion for Intramuscular
|
90 degrees dart
|
|
|
Z- track Method
|
Change needle to 1 1/2" after drawing up med
Draw up 0.2 cc air lock Pull skin to lateral or medial aspect of buttock Wait 10 seconds, remove needle quickly |
|
|
The characteristic of the tissues influences what?
|
The rate of medication absorption and thus the onset of medication action
|
|
|
Before injecting a medication, the nurse should what?
|
know the volume of the medication to administer, the medication's characteristics and viscosity, and the location of anatomical structures underlying injection sites.
|
|
|
Inability to maintain stability of the needle and syringe unit could result in what?
|
pain for the client and possibly tissue damage
|
|
|
If the nurse fails to aspirate the syringe before injecting an intramuscular medication, what could happen?
|
the medication may accidently be injected directly into an artery or vein.
|
|
|
Injecting too large a volume of medication for a site could result in what?
|
extreme pain and may result in local tissue damage
|
|
|
Assess for contraindications for Sub-Q injections
|
Assess for factors such as circulatory shock or reduced local tissue perfusion. Assess adequacy of client's adipose tissue.
|
|
|
Assess for contraindications for Intramuscular injections
|
Assess for factors such as muscle atrophy, reduced blood flow, or circulatory shock
|
|
|
What do you inspect before giving an injection?
|
skin surface over sites for bruises, inflammation, or edema
|
|
|
When selecting appropriate injection site, what do you look at for Sub-Q?
|
palpate sites for masses or tenderness. Avoid these areas. Be sure needle is correct size by grasping skinfold at site with thumb and forefinger. Measure fold from top to bottom. Needle should be one half length.
|
|
|
When selecting appropriate injection site, what do you look at for IM?
|
Note integrity and size of muscle and palpate for tenderness or hardness. Avoid these areas. If injections are given frequently, rotate sites
|
|
|
When selecting appropriate injection site, what do you look at for ID?
|
Note lesions or discolorations of forearm. Select site three or four fingerwidths below antecubital space and a handwidth above the wrist. If forearm cannot be used, inspect the upper back. If necessary, sites for Sub-Q injections may be used.
|
|
|
What is a comfortable position for Sub-Q?
|
Have client relax arm, leg, or abdomen, depending on site chosen for injection
|
|
|
What is a comfortable position for IM?
|
Have client lie flat, on side, or prone, depending on site chosen
|
|
|
What is a comfortable position for ID?
|
Have clientextend elbow and support it and forearm on flat surface
|
|
|
What site is preferred for children older than 7 months and adults unless there are contraindications?
|
ventrogluteal
|
|
|
What site is preferred for infants younger than 7 months?
|
Vastus Lateralis
|
|
|
When giving an injection, how do you hold the needle for Sub-Q?
|
hold as dart, palm down or hold syringe across tops of fingertips
|
|
|
When giving an injection, how do you hold the needle for IM?
|
Hold as dart, palm down
|
|
|
When giving an injection, how do you hold the needle for ID?
|
Hold bevel of needle pointing up
|
|
|
What does Z-track do?
|
creates zigzag path through tissues that seals needle track to avoid tracking of medication.
|
|
|
How long do you stay with a client after injection is given to observe for allergic reaction?
|
3 to 5 minutes
|
|
|
After given an ID injection, what do you do?
|
use skin pencil and draw circle around perimeter of injection site. Read site within 48 to 72 hours of injection
|
